Definitive Contract HHSN261201200032C

Award Date 9/28/12
Potential Completion Date 6/27/13
Potential Value $200K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Miami, FL 33131, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
The National Cancer Institute (NCI) awarded a Cost Plus Fixed Fee contract to Infotech Soft, Inc., a woman-owned small business, for a Mobile Clinical Trials Data Collection System. The contract has a ceiling value of $1,509,026.00 and a period of performance through May 31, 2008. This definitive contract was not set aside under any special programs. The system developed under this contract supports NCI's clinical trials research efforts by enabling mobile data collection capabilities....
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
The U.S. National Cancer Institute (part of the Department of Health and Human Services) awarded a $167,145.16 firm fixed-price delivery order contract to New TECH Solutions, Inc., a small business prime contractor, to provide software under the Chief Information Officer Commodities and Solutions (CIO-CS) government-wide acquisition contract. The contract has a period of performance through July 31, 2025 and does not have a set-aside designation. New TECH Solutions is an 8(a) certified...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Infotech Soft Inc., a woman-owned small business. The $224,683 firm fixed-price contract is for the "SBIR TOPIC 341 PH I METABOLOMICS DATA INTEGRATION AND QUALITY ASSESSMENT" project, which aims to develop advanced technological solutions for medical research and diagnostic capabilities. The contract has a total small business set-aside designation and was awarded on...
This is a $16,417,703.20 federal contract awarded by the National Institutes of Health (NIH) to Soft TECH Consulting, Inc., a woman-owned, minority-owned small business IT consulting firm. The contract is for information technology services and support for the National Cancer Institute (NCI) Division of Cancer Control and Population Science (DCCPS). The contract is a delivery order under the GSA Multiple Award Schedule and has a period of performance through March 8, 2026. The contract vehicle...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $42,551.84 firm fixed price delivery order against the Chief Information Officer Commodities and Solutions (CIO-CS) government-wide acquisition contract to New TECH Solutions, Inc. for software. The delivery order has a period of performance through February 2025 and was awarded on February 15, 2024 without a set aside designation. New TECH Solutions, Inc. will provide the software...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a $1,990,308.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Neuralrad LLC, a small business, for the development of quantitative imaging software tools for cancer diagnosis and treatment planning. The contract is set aside for small businesses and has an ultimate completion date of August 27, 2026. The software tools are being developed under the NCI's Small Business Innovation Research (SBIR) program, specifically under...
<p>The National Cancer Institute (NCI) awarded a $199,996.00 Firm Fixed Price contract to Operational Technologies Corporation, a minority-owned, small disadvantaged, veteran-owned business, for Research &amp; Development in Biomedical Basic Research. The contract has a completion date of June 22, 2014 and was set aside for small businesses. As a civilian agency, the NCI focuses on cancer research and this contract contributes to their broader medical research initiatives.</p>

The U.S. National Cancer Institute (NCI) awarded a $199,969.00 firm fixed-price definitive contract to Infotech Soft, Inc., a woman-owned small business, for the development of an "Other Functions Scalable Automated Brain Tumor Segmentation" solution. The contract was awarded on September 28, 2012, with a completion date of June 27, 2013. Infotech Soft, Inc. has a proven track record of delivering specialized software solutions and research services to various federal healthcare agencies, including the National Institute of Allergy and Infectious Diseases (NIAID) and the NCI. The contract is set aside for small businesses, aligning with the NCI's priorities of supporting the development of innovative technologies to improve cancer diagnosis and treatment.

Generated 11/24/24, 9:32 AM